Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: August 7, 2000
Last updated: July 8, 2013
Last verified: July 2013